Robert Donnell is Head of Business Development at Durbin a leading provider of unlicienced medications to patients with un-met medical needs. Durbin conducts Managed Access Programs (MAPs), Named patient and Compassionate Use programs on behalf of global pharmaceutical and specialist biotech companies.
Durbin is head quartered in the UK and distributes to more than 180 differing territories.
He started his career with Procter & Gamble Pharmaceuticals and Astra Zeneca in a variety of sales and marketing positions before founding a Consultancy company specializing in educating Pharmaceutical and Biotech companies on how to interact with the UK government.
At Durbin, Robert focuses on providing strategic advice to blue chip Pharmaceutical and Biotech companies on how to deliver innovative cost effective strategies for international distribution and clinical outsourcing.
Robert is a frequent speaker at international conferences lecturing on a variety of specialist sourcing and distribution issues for the Healthcare industry. Robert has advised several UK Members of Parliament on the Healthcare Industry